CLINICAL TRIALS & RESEARCH
Resources

Response to FDA’s request for comments on strategic priorities for the Office of Minority Health and Health Equity (OMHHE)

Public Comments

Comments provided on: June 29, 2020

Comments provided to: Food and Drug Administration (FDA)